Compliance and persistence should be an integral part of clinical (observational) studies and pharmacoeconomic analyses in order to estimate the cost–effectiveness of drug therapies in current ...

and pharmacoeconomic analysis. Joseph’s most recent experience was in leading the oncology medical affairs team for a large Fortune 100 pharmaceutical company in the US. In this capacity ...

Keywords: Allergic rhinitis, Biologic therapies, Allergen immunotherapy, Monoclonal antibodies, Pharmacoeconomic analysis Important Note: All contributions to this Research Topic must be within the ...

For example, self-funding interventional pharmacoeconomic (IVPE) trials can identify affordable alternatives to high-cost therapies, where the cost savings of payers during the trial exceed its ...

A forum for the dissemination of clinical, pharmacoeconomic, and regulatory information to payers, health care policy experts, and providers associated with cancer care.

Mustafa & Sanober Lokhandwala Endowed Professor of Pharmaceutical Health Outcomes & Policy, Department Chair, and Director, Center for Population Health Outcomes and Pharmacoepidemiology Education and ...

Instead, if they could think about the real value of vaccines in preventing diseases and the overall pharmacoeconomic cost-savings, we could have a healthy society. What factors have influenced ...

Purpose. The chemistry, pharmacology, antimicrobial activity, pharmacokinetics, pharmacodynamics, efficacy and safety in humans, and formulary considerations of doripenem are reviewed. Summary ...

The research analyzed drugs approved by Health Canada from 2015 to 2021 with available pharmacoeconomic information published by the Canadian Agency for Drugs and Technologies in Health (CADTH). The ...

Introduction South Africa experiences significant levels of alcohol-related harm. Recent research suggests minimum unit pricing (MUP) for alcohol would be an effective policy, but high levels of ...